Cargando…

TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study

Recent advances in the development of chemotherapies have helped improve the prognosis of pancreatic ductal adenocarcinoma (PDAC). However, predicting factors for the outcomes of chemotherapies (either gemcitabine or S-1) have not yet been established. We analyzed the expression of 4 major epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujiwara, Sho, Saiki, Yuriko, Fukushige, Shinichi, Yamanaka, Mie, Ishida, Masaharu, Motoi, Fuyuhiko, Unno, Michiaki, Horii, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110717/ https://www.ncbi.nlm.nih.gov/pubmed/36764935 http://dx.doi.org/10.1007/s00595-023-02655-3

Ejemplares similares

Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
por: Fujiwara, Sho, et al.
Publicado: (2019)

Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
por: Motoi, Fuyuhiko, et al.
Publicado: (2020)

Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer
por: Chakma, Kanchan, et al.
Publicado: (2020)

Targeted TET oxidase activity through methyl‐CpG‐binding domain extensively suppresses cancer cell proliferation
por: Mizuguchi, Yasuhiko, et al.
Publicado: (2016)

Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population
por: Hata, Tatsuo, et al.
Publicado: (2021)

Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7
por: Miyauchi, Toshiya, et al.
Publicado: (2021)

GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype
por: Hata, Tatsuo, et al.
Publicado: (2020)

Lymph node resection induces the activation of tumor cells in the lungs
por: Sukhbaatar, Ariunbuyan, et al.
Publicado: (2019)

Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
por: Hirosawa, Takashi, et al.
Publicado: (2018)

The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation
por: Yoshimatsu, Gumpei, et al.
Publicado: (2015)

Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
por: Shima, Kentaro, et al.
Publicado: (2012)

Surgical anatomy of the right hepatic artery in Rouviere’s sulcus evaluated by preoperative multidetector-row CT images
por: Aoki, Shuichi, et al.
Publicado: (2016)

Metastasis of ovarian cancer to the bile duct: a case report
por: Shijo, Masahiro, et al.
Publicado: (2019)

Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance
por: Saiki, Yuriko, et al.
Publicado: (2020)

Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients
por: Aoki, Shuichi, et al.
Publicado: (2019)

Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer
por: Ishikawa, Tomohiko, et al.
Publicado: (2023)

A GNAS Mutation Found in Pancreatic Intraductal Papillary Mucinous Neoplasms Induces Drastic Alterations of Gene Expression Profiles with Upregulation of Mucin Genes
por: Komatsu, Hirotake, et al.
Publicado: (2014)

Imaging of transplanted islets by positron emission tomography, magnetic resonance imaging, and ultrasonography
por: Sakata, Naoaki, et al.
Publicado: (2013)

Intraoperative ultrasound examination is useful for monitoring transplanted islets: A case report
por: Sakata, Naoaki, et al.
Publicado: (2012)

Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size
por: Kurata, Masanao, et al.
Publicado: (2017)

Cystic Lymphangioma of the Pancreas with Spontaneous Rupture: Report of a Case
por: Kawaguchi, Kei, et al.
Publicado: (2011)

Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report
por: Ariake, Kyohei, et al.
Publicado: (2017)

Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
por: Okabayashi, Takehiro, et al.
Publicado: (2022)

Nanobubble technology to treat spinal cord ischemic injury
por: Naganuma, Masaaki, et al.
Publicado: (2020)

Expression of Epithelial-Mesenchymal Transition Proteins in Pancreatic Anaplastic (Undifferentiated) Carcinoma
por: Ishida, Kazuyuki, et al.
Publicado: (2019)

Repeated Pancreatectomy for Metachronous Duodenal and Pancreatic Metastases of Renal Cell Carcinoma
por: Hata, Tatsuo, et al.
Publicado: (2013)

Levels of tumor markers CEA/CA 19–9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer
por: Hata, Tatsuo, et al.
Publicado: (2022)

A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane
por: Saiki, Yuriko, et al.
Publicado: (2011)

Extracellular Matrix and Growth Factors Improve the Efficacy of Intramuscular Islet Transplantation
por: Tsuchiya, Haruyuki, et al.
Publicado: (2015)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients
por: Sato, Naoko, et al.
Publicado: (2018)

Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan
por: Aoki, Shuichi, et al.
Publicado: (2017)

Pancreatic neuroendocrine tumor with complete replacement of the pancreas by serous cystic neoplasms in a patient with von Hippel-Lindau disease: a case report
por: Maeda, Shimpei, et al.
Publicado: (2017)

Overcoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
por: Motoi, Fuyuhiko
Publicado: (2021)

Implanted markers prior to neoadjuvant chemotherapy: preliminary report
por: Allan for the Dartford Breast Care Team, DM
Publicado: (2000)

Defining the Optimal Method for Measuring Metabolic Tumor Volume on Preoperative (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography as a Prognostic Predictor in Patients With Pancreatic Ductal Adenocarcinoma
por: Tatewaki, Yasuko, et al.
Publicado: (2021)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
por: Ohnuma, Hiroyuki, et al.
Publicado: (2018)

Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery
por: Satoi, Sohei, et al.
Publicado: (2018)

Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis
por: Takenami, Tsutomu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_41tn6g03o61ip1i3lgr2vjrd0f